Fundraising FoxMabGenesis
6 known investors
Find your way into MabGenesis
Sign up to find every way you can get introduced to MabGenesis
- Your email: who you already know at MabGenesis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MabGenesis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use. Using its MOURA antibody library and IMPACT high-efficiency monoclonal antibody isolation technology, it targets high-unmet-need areas such as cancer and zoonotic diseases, and has built dog and cat antibody libraries for the veterinary drug market.
Investors · 6
Also in the syndicate · 3
Axil Capital PartnersMiyazaki Taiyo CapitalREVIC Capital
Frequently asked questions
- What does MabGenesis do?
- MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use. Using its MOURA antibody library and IMPACT high-efficiency monoclonal antibody isolation technology, it targets high-unmet-need areas such as cancer and zoonotic diseases, and has built dog and cat antibody libraries for the veterinary drug market.
- Who are MabGenesis's investors?
- MabGenesis's investors include Beyond Next Ventures, Axil Capital, Long Black Partners.